Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
作者信息
John Thadathilankal-Jess, John Kiran
机构信息
Division of Cardiology, Department of Medicine, Stellenbosch University & Tygerberg Academic Hospital, Cape Town, South Africa.
Division of General Internal Medicine, Department of Medicine, Stellenbosch University & Tygerberg Academic Hospital, Cape Town, South Africa.
出版信息
Eur Heart J. 2020 Jun 7;41(22):2126-2127. doi: 10.1093/eurheartj/ehaa423.
Abstract
摘要
相似文献
1
Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.肾素-血管紧张素-醛固酮系统失调与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染
Eur Heart J. 2020 Jun 7;41(22):2126-2127. doi: 10.1093/eurheartj/ehaa423.
2
A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.全激酶组小干扰RNA筛选鉴定出严重急性呼吸综合征冠状病毒复制中的前病毒和抗病毒宿主因子，包括双链RNA激活蛋白激酶和早期分泌途径蛋白。
J Virol. 2015 Aug;89(16):8318-33. doi: 10.1128/JVI.01029-15. Epub 2015 Jun 3.
3
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.严重急性呼吸综合征与中东呼吸综合征。
Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046.
4
[Coronaviruses as the cause of respiratory infections].[冠状病毒作为呼吸道感染的病因]
Internist (Berl). 2019 Nov;60(11):1136-1145. doi: 10.1007/s00108-019-00671-5.
引用本文的文献
1
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.与 COVID-19 大流行相关的 SARS-CoV-2 的免疫反应和潜在治疗策略。
Int J Biol Sci. 2022 Feb 14;18(5):1865-1877. doi: 10.7150/ijbs.66369. eCollection 2022.
2
The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review.肾素-血管紧张素系统、高血压与 SARS-CoV-2 感染：综述。
Curr Hypertens Rep. 2021 Mar 25;23(4):17. doi: 10.1007/s11906-021-01134-9.
3
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.中草药：全方位抗击 SARS-CoV-2 感染。
J Ethnopharmacol. 2021 Apr 24;270:113869. doi: 10.1016/j.jep.2021.113869. Epub 2021 Jan 21.
4
The saga continues: is COVID-19 a cardiopulmonary disease?故事仍在继续：新冠病毒肺炎是一种心肺疾病吗？
Eur Heart J. 2020 Jun 7;41(22):2041-2044. doi: 10.1093/eurheartj/ehaa502.
5
Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.肾素-血管紧张素系统与新型冠状病毒2感染：有一个前后对比情况。
Eur Heart J. 2020 Jun 7;41(22):2128-2129. doi: 10.1093/eurheartj/ehaa451.
本文引用的文献
1
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?严重急性呼吸综合征冠状病毒2：2019冠状病毒病患者是否应停用肾素-血管紧张素系统抑制剂？
Eur Heart J. 2020 May 14;41(19):1801-1803. doi: 10.1093/eurheartj/ehaa235.
2
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.从 2019 年新冠病毒感染患者中提取的临床和生化指标与病毒载量和肺部损伤有关。
Sci China Life Sci. 2020 Mar;63(3):364-374. doi: 10.1007/s11427-020-1643-8. Epub 2020 Feb 9.
3
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.一项重组人血管紧张素转换酶 2 在急性呼吸窘迫综合征中的临床试验。
Crit Care. 2017 Sep 7;21(1):234. doi: 10.1186/s13054-017-1823-x.
4
Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.血管紧张素II通过激活核因子κB刺激培养的人脂肪细胞释放白细胞介素-6和白细胞介素-8。
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1199-203. doi: 10.1161/01.ATV.0000131266.38312.2e. Epub 2004 May 6.
Zotero 插件